160 related articles for article (PubMed ID: 11465430)
1. The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery.
Briones M; Singh M; Ugozzoli M; Kazzaz J; Klakamp S; Ott G; O'Hagan D
Pharm Res; 2001 May; 18(5):709-12. PubMed ID: 11465430
[No Abstract] [Full Text] [Related]
2. Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.
Singh M; Ott G; Kazzaz J; Ugozzoli M; Briones M; Donnelly J; O'Hagan DT
Pharm Res; 2001 Oct; 18(10):1476-9. PubMed ID: 11697476
[No Abstract] [Full Text] [Related]
3. The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance.
Singh M; Ugozzoli M; Briones M; Kazzaz J; Soenawan E; O'Hagan DT
Pharm Res; 2003 Feb; 20(2):247-51. PubMed ID: 12636163
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity.
Singh M; Vajdy M; Gardner J; Briones M; O'Hagan D
Vaccine; 2001 Nov; 20(3-4):594-602. PubMed ID: 11672926
[TBL] [Abstract][Full Text] [Related]
5. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
[TBL] [Abstract][Full Text] [Related]
6. Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles.
Otten G; Schaefer M; Greer C; Calderon-Cacia M; Coit D; Kazzaz J; Medina-Selby A; Selby M; Singh M; Ugozzoli M; zur Megede J; Barnett SW; O'Hagan D; Donnelly J; Ulmer J
J Virol; 2003 May; 77(10):6087-92. PubMed ID: 12719603
[TBL] [Abstract][Full Text] [Related]
7. Microparticles for the delivery of DNA vaccines.
O'Hagan DT; Singh M; Ulmer JB
Immunol Rev; 2004 Jun; 199():191-200. PubMed ID: 15233735
[TBL] [Abstract][Full Text] [Related]
8. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.
Denis-Mize KS; Dupuis M; MacKichan ML; Singh M; Doe B; O'Hagan D; Ulmer JB; Donnelly JJ; McDonald DM; Ott G
Gene Ther; 2000 Dec; 7(24):2105-12. PubMed ID: 11223992
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention.
Ruberti M; De Melo LK; Dos Santos SA; Brandao IT; Soares EG; Silva CL; Júnior JM
J Drug Target; 2004 May; 12(4):195-203. PubMed ID: 15506168
[TBL] [Abstract][Full Text] [Related]
10. Cationic microparticles: A potent delivery system for DNA vaccines.
Singh M; Briones M; Ott G; O'Hagan D
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):811-6. PubMed ID: 10639162
[TBL] [Abstract][Full Text] [Related]
11. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
Delgado A; Lavelle EC; Hartshorne M; Davis SS
Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
[TBL] [Abstract][Full Text] [Related]
12. Oral plasmid DNA delivery systems for genetic immunisation.
Somavarapu S; Bramwell VW; Alpar HO
J Drug Target; 2003; 11(8-10):547-53. PubMed ID: 15203924
[TBL] [Abstract][Full Text] [Related]
13. Synergistic adjuvant activity of immunostimulatory DNA and oil/water emulsions for immunization with HIV p55 gag antigen.
O'Hagan DT; Singh M; Kazzaz J; Ugozzoli M; Briones M; Donnelly J; Ott G
Vaccine; 2002 Sep; 20(27-28):3389-98. PubMed ID: 12213409
[TBL] [Abstract][Full Text] [Related]
14. Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres.
Zhao K; Li GX; Jin YY; Wei HX; Sun QS; Huang TT; Wang YF; Tong GZ
J Microencapsul; 2010; 27(2):178-86. PubMed ID: 20121488
[TBL] [Abstract][Full Text] [Related]
15. Microparticle delivery of plasmid DNA to mammalian cells.
Hedley ML; Barman SP
Methods Mol Biol; 2004; 245():265-86. PubMed ID: 14707387
[No Abstract] [Full Text] [Related]
16. A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2.
Singh M; Carlson JR; Briones M; Ugozzoli M; Kazzaz J; Barackman J; Ott G; O'Hagan D
Vaccine; 1998 Nov; 16(19):1822-7. PubMed ID: 9795387
[TBL] [Abstract][Full Text] [Related]
17. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
Pai Kasturi S; Qin H; Thomson KS; El-Bereir S; Cha SC; Neelapu S; Kwak LW; Roy K
J Control Release; 2006 Jul; 113(3):261-70. PubMed ID: 16793161
[TBL] [Abstract][Full Text] [Related]
19. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
Uchida T; Goto S
Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
[TBL] [Abstract][Full Text] [Related]
20. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.
Moore A; McGuirk P; Adams S; Jones WC; McGee JP; O'Hagan DT; Mills KH
Vaccine; 1995 Dec; 13(18):1741-9. PubMed ID: 8701587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
